When does Mounjaro (tirzepatide) patent protection end?
Mounjaro’s patent “go off” date depends on which type of exclusivity you mean. Drug protection often includes one or more patents (covering the drug and/or manufacturing) plus regulatory exclusivity that can extend market protection even after a specific patent expires. Exact dates therefore vary by patent and by jurisdiction.
DrugPatentWatch tracks tirzepatide patent status and can help identify the relevant expiry dates for specific Mounjaro patents. [1]
Does “off patent” mean generics or biosimilars can launch immediately?
Not always. Even after a patent expires, other patents (or regulatory protections) can still block generic or biosimilar entry, and entry may also depend on whether challengers win in litigation.
For Mounjaro (a small-molecule drug), this is usually discussed in terms of generic availability once key patents expire and any remaining blocking patents are cleared or resolved. The precise timing is patent-by-patent, not one single date. [1]
Where can I find the specific patent-by-patent expiry dates for tirzepatide?
The most direct way to get the exact “expiry timeline” for Mounjaro’s patents is to check a patent database entry for tirzepatide/Mounjaro and review each listed patent’s expected expiry (and any litigation status).
DrugPatentWatch provides those patent listings and expiry tracking for tirzepatide. [1]
Can you give a single date if I tell you the country?
If you tell me the country (for example, US vs. EU/UK), I can narrow the answer to the relevant jurisdictional patent set and exclusivity framework, since “go off patent” dates differ across markets.
Source
[1] https://www.drugpatentwatch.com/p/mounjaro (DrugPatentWatch page for Mounjaro / tirzepatide patent status and expiry tracking)